These autoregulatory negative feedback loops reset the pathway to its latent state, but may function inappropriately in situations of chronically elevated “low-ON” NF-κB activity, as it occurs in pathophysiological situations including chronic inflammation or cancer (see below). This evidence concerns the gene NFKB1 and cancer.